BRPI0509667B8 - composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto - Google Patents

composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto

Info

Publication number
BRPI0509667B8
BRPI0509667B8 BRPI0509667A BRPI0509667A BRPI0509667B8 BR PI0509667 B8 BRPI0509667 B8 BR PI0509667B8 BR PI0509667 A BRPI0509667 A BR PI0509667A BR PI0509667 A BRPI0509667 A BR PI0509667A BR PI0509667 B8 BRPI0509667 B8 BR PI0509667B8
Authority
BR
Brazil
Prior art keywords
compound
preparation
medicine
formula
azaquinazolines
Prior art date
Application number
BRPI0509667A
Other languages
English (en)
Inventor
Lang Dieter
Süssmeier Frank
Zimmermann Holger
Baumeister Judith
Henninger Kerstin
Jeske Mario
Wunberg Tobias
Original Assignee
Aicuris Anti Infective Cures Gmbh
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Anti Infective Cures Gmbh, Aicuris Gmbh & Co Kg filed Critical Aicuris Anti Infective Cures Gmbh
Publication of BRPI0509667A publication Critical patent/BRPI0509667A/pt
Publication of BRPI0509667B1 publication Critical patent/BRPI0509667B1/pt
Publication of BRPI0509667B8 publication Critical patent/BRPI0509667B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

azaquinazolinas substituídas com eficácia antiviral. a invenção refere-se a azaquinozolinas e a processo para sua preparação, assim como ao emprego como agente antiviral, particularmente contra citomegalovírus.
BRPI0509667A 2004-05-07 2005-04-23 composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto BRPI0509667B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004022672.5 2004-05-07
DE102004022672A DE102004022672A1 (de) 2004-05-07 2004-05-07 Substituierte Azachinazoline
PCT/EP2005/004384 WO2005113552A1 (de) 2004-05-07 2005-04-23 Substituierte azachinazoline mit antiviraler wirkung

Publications (3)

Publication Number Publication Date
BRPI0509667A BRPI0509667A (pt) 2007-10-09
BRPI0509667B1 BRPI0509667B1 (pt) 2019-11-26
BRPI0509667B8 true BRPI0509667B8 (pt) 2021-05-25

Family

ID=34969190

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509667A BRPI0509667B8 (pt) 2004-05-07 2005-04-23 composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto

Country Status (11)

Country Link
US (2) US7662822B2 (pt)
EP (1) EP1751155B1 (pt)
JP (1) JP4928444B2 (pt)
CN (1) CN1980925B (pt)
AT (1) ATE420089T1 (pt)
AU (1) AU2005245536B2 (pt)
BR (1) BRPI0509667B8 (pt)
CA (1) CA2565761C (pt)
DE (2) DE102004022672A1 (pt)
ES (1) ES2318492T3 (pt)
WO (1) WO2005113552A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
DE10305785A1 (de) * 2003-02-12 2004-08-26 Bayer Healthcare Ag Dihydrochinazoline
DE10320780A1 (de) * 2003-05-09 2005-01-20 Bayer Healthcare Ag Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) * 2003-11-11 2005-06-09 Bayer Healthcare Ag Substituierte Dihydrochinazoline II
DE102004022672A1 (de) * 2004-05-07 2005-11-24 Bayer Healthcare Ag Substituierte Azachinazoline
DE102005027517A1 (de) 2005-06-15 2006-12-21 Bayer Healthcare Ag Verfahren zur Herstellung von Dihydrochinazolinen
CN109476677B (zh) * 2016-08-08 2024-06-07 辉诺生物医药科技（杭州）有限公司 抗hcmv病毒化合物
AU2019218150B2 (en) * 2018-02-08 2021-05-13 Phaeno Therapeutics Co., Ltd. Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854245A (en) 1996-06-28 1998-12-29 Merck & Co., Inc. Fibrinogen receptor antagonists
JP2002503662A (ja) 1998-02-17 2002-02-05 テュラリク インコーポレイテッド 抗ウイルス性ピリミジン誘導体
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
DE60113865T2 (de) 2000-07-31 2006-07-20 Vernalis Research Ltd., Winnersh Piperazin derivate
EP1201765A3 (en) 2000-10-16 2003-08-27 Axxima Pharmaceuticals Aktiengesellschaft Cellular kinases involved in cytomegalovirus infection and their inhibition
DE10251914A1 (de) 2002-11-08 2004-05-19 Bayer Ag Substituierte Chinazoline
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
DE10305785A1 (de) 2003-02-12 2004-08-26 Bayer Healthcare Ag Dihydrochinazoline
DE10320780A1 (de) 2003-05-09 2005-01-20 Bayer Healthcare Ag Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) 2003-11-11 2005-06-09 Bayer Healthcare Ag Substituierte Dihydrochinazoline II
KR100610731B1 (ko) 2004-02-24 2006-08-09 한국과학기술연구원 Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법
DE102004022672A1 (de) 2004-05-07 2005-11-24 Bayer Healthcare Ag Substituierte Azachinazoline
NZ560320A (en) 2005-01-25 2011-02-25 Prolexys Pharmaceuticals Inc Quinoxaline derivatives as antitumor agents
DE102005027517A1 (de) 2005-06-15 2006-12-21 Bayer Healthcare Ag Verfahren zur Herstellung von Dihydrochinazolinen
WO2007009911A1 (en) * 2005-07-21 2007-01-25 F. Hoffmann-La Roche Ag PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS

Also Published As

Publication number Publication date
EP1751155A1 (de) 2007-02-14
WO2005113552A1 (de) 2005-12-01
BRPI0509667A (pt) 2007-10-09
JP2007536297A (ja) 2007-12-13
JP4928444B2 (ja) 2012-05-09
CN1980925A (zh) 2007-06-13
HK1112228A1 (zh) 2008-08-29
US8198282B2 (en) 2012-06-12
CN1980925B (zh) 2012-01-11
ES2318492T3 (es) 2009-05-01
US20100179174A1 (en) 2010-07-15
DE502005006427D1 (de) 2009-02-26
AU2005245536B2 (en) 2011-01-20
US7662822B2 (en) 2010-02-16
US20080132515A1 (en) 2008-06-05
EP1751155B1 (de) 2009-01-07
AU2005245536A1 (en) 2005-12-01
CA2565761A1 (en) 2005-12-01
DE102004022672A1 (de) 2005-11-24
BRPI0509667B1 (pt) 2019-11-26
ATE420089T1 (de) 2009-01-15
CA2565761C (en) 2012-10-02

Similar Documents

Publication Publication Date Title
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
NL300933I2 (nl) Letermovir
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
DOP2007000051A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
BRPI0514691A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
GB0625648D0 (en) Compounds
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
ME01456B (me) Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BRPI0409454A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com o receptor de glucagon e sua utilização
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
ECSP099425A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2
TW200738659A (en) Novel compounds
UY29648A1 (es) Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
TW200745122A (en) New compounds I
TW200640863A (en) Compounds which potentiate glutamate receptor and uses thereof in medicine
UY28248A1 (es) Compuestos quinicos
SE0403086D0 (sv) Compounds
ATE380188T1 (de) Substituierte chinolone

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: AICURIS ANTI-INFECTIVE CURES GMBH (DE)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/11/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/11/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved

Owner name: AICURIS ANTI-INFECTIVE CURES AG (DE)

B25A Requested transfer of rights approved

Owner name: AIC246 GMBH AND CO. KG (DE)

B25D Requested change of name of applicant approved

Owner name: AIC246 AG AND CO. KG (DE)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.